Type 1, and Type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases

Clinical Microbiology Reviews

Volumn 9, Issue 4, 1996, Pages 532-562

  Lucey, Daniel R ^a,c   Clerici, Mario ^b   Shearer, Gene M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN;

B LYMPHOCYTE; BASOPHIL; CANCER; CELLULAR IMMUNITY; EOSINOPHIL; EOSINOPHILIA; GRANULOMATOSIS; HELPER CELL; HUMORAL IMMUNITY; HYPERGAMMAGLOBULINEMIA; IMMUNE SYSTEM; INFECTION; INFLAMMATION; LYMPHOCYTE CLONE; MAST CELL; MONOCYTE; NATURAL KILLER CELL; NOMENCLATURE; REVIEW;

FUNGI; MURINAE;

EID: 0029859871     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.9.4.532     Document Type: Review

References (433)

1. Actor, J. K., M. A. Marshall, I. A. Eltoum, R. M. Buller, J. A. Berzofsky, and A. Sher. 1994. Increased susceptibility of mice infected with Schistosoma mansōni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. Eur. J. Immunol. 24:3050-3056.
2. Actor, J. K., M. Shirai, M. Kullberg, R. M. Buller, A. Sher, and J. A. Berzofsky. 1993. Helminth infection results in decreases virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. USA 90:948-952
3. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of IL-12 in a vaccine against Leishmania major. Science 263:235-237.
4. Agnarsson, B. A., and M. E. Kadin. 1988 Ki-1 positive large cell lymphoma: a morphologic and immunologic study of 19 cases. Am. J. Surg. Pathol. 12:264-274.
5. Allison, A. C, and N. E. Byars. 1991. Immunological adjuvants: desirable properties and side effects. Mol. Immunol. 28:279-284.
6. Alzona, M., H.-M. Jack, R. I. Fisher, and T. M. Ellis. 1994. CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153:2861-2867.
7. Alzona, M., H.-M. Jack, R. I. Fisher, and T. M. Ellis. 1995. IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells. J. Immunol. 154:9-16.
8. Amiri, P., R. M. Locksley, T. G. Parslow, M. Sadick, E. Rector, D. Ritter, and J. H. McKerrow. 1992. Tumor necrosis factor alpha restores granuloma and induces parasite egg-laying in schistosome-infected SCID mice. Nature (London) 356:604-607.
9. Anderson, L. J., and C. A. Heilman. 1995. Protective and disease-enhancing immune responses to respiratory syncytial virus. J. Infect Dis. 171:1-7.
10. Anderson, L. J., C. Tsou, C. Potter, H. L. Keyserling, T. F. Smith, G. Ananaba, and C. R. M. Bangham. 1994. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J. Infect. Dis. 170:1201-1208.
11. Andersson, J., and U. Andersson. 1993. Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood. Clin. Exp. Immunol 92:7-13.
12. Armitage, R. J., B. M. Macduff, J. Eisenman, R. Paxton, and K. H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol 154:483-490.
13. Assaad, F. 1983. Measles: summary of worldwide impact Rev. Infect. Dis. 5:452-459.
14. Autran, B., E. Legac, C. Blanc, and P. Debre. 1995. A Th0,Th2-like function of CD4+ CD7- T helper cells from normal donors and HTV-infected patients. J. Immunol 154:1408-1417.
15. Bamford, R. N., A. J. Grant, J. D. Burton, C Peters, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. The interleukin (IL) 2 receptor ß chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940-4944.
16. Barcellini, W., G. P. Rizzardi, M. O. Borghi, C. Fain, A. Lazzarin, and P. L. Meroni. 1994. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 8:757-762.
17. Barnaba, V., A. Franco, M. Paroli, R. Benvenute, G. De Petrillo, V. L. Colizzi, G. Cutrona, and M. Ferrariai. 1994. Selective expansion of cytotoxic T lymphocytes with a CD4+ CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J. Immunol. 152:3074-3087.
18. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by mycobacterium tuberculosis lipoarabinomannan: relationship to chemical structure, J. Immunol 149:541-547.
19. Barnes, P. F., S.-J. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J. Immunol. 145:149-154.
20. Barnes, P. J., and F. Y. Liew. 1995. Nitric oxide and asthmatic inflammation. Immunol. Today 16:128-130.
21. Beaman, L. 1991. Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Caccidioides immitis. Infect Immun. 59:4227-4229.
22. Beck, J. T., S.-M. Hsu, J. Wijdenes, R. Bataille, B. Klein, D. Vesole, K. Hayden, S. Jagannath, and B. Barlogie. 1994. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N. Engl J. Med. 330:602-605.
23. Beninati, W., S. Derdak, P. F. Dixon, D. J. Grider, D. C. Strollo, R. E. Hensley, and D. R. Luncey. 1993. Pulmonary-eosinophils express HLA-DR in chronic eosinophilic pneumonia. J. Allergy Clin. Immunol. 92:442-449.
24. Benjamin, D., T. J. Knobloch, and M. A. Dayton. 1992 Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289-1298.
25. Benvenuto, R., M. Paroli, C. Buttinelli, A. Franco, V. Barnaba, C. Fieschi, and F. Balsano. 1992. Tumor necrosis factor alpha and interferon-gamma synthesis by cerebrospinal fluid-derived T cell clories in multiple sclerosis. Ann. N. Y. Acad. Sci. 650:341-346.
26. Bermas, B. I., M. Petri, D. Goldman, B. Mittleman, M. W. Miller, N. I. Stocks, C. S. Via, and G. M. Shearer. 1994. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J. Clin. Immunol. 14:169-177.
27. Bermudez, L. E., and J. Champsi. 1993. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect. Immun. 61:3093-3097.
28. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108-113.
29. Blatt, S., C. W. Hendrix, C. A. Butzin, T. M. Freeman, W. W. Ward, R. E. Hensley, G. P. Melcher, D. J. Donovan, and R. N. Boswell. 1993. Delayed type hypersensitivity testing predicts progression to AIDS in HIV infected patients. Ann. Intern. Med. 119:177-184.
30. Blay, R., D. Hernandez, M. Betts, M. Clerici, D. R. Lacey, C. Hendrix, T. Hoffman, and B. Golding. 1992. Brucella abortus stimulates human T cells from uninfected and HIV-infected individuals to secrete IFN-gamma: implications for use of Brucella abortus as a carrier in development of human vaccines. AIDS Res. Hum. Rettoviruses 8:479-486.
31. Bloom, B. R. 1993. The power of negative thinking. J. Clin. Invest. 91:1265-1266.
32. Bloom, B. R., and P. E. M. Fine. 1994. The BCC experience: implications for future vaccines against tuberculosis, p. 531-557. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
33. Bloom, B. R., P. Salgame, and B. Diamond. 1992. Revisiting and revising suppressor T cells. Immunol. Today 13:131-136.
34. Bollinger, R. C., T. C. Quinn, A. Y. Liu, P. E. Stanhope, S. A. Hammond, R. Viveen, M. L. Clements, and R. F. Siliciano. 1993. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication. AIDS Res. Hum. Retroviruses 9:1067-1077.
35. Borrow, P., H. Lewicki, B. H. Habn, G. M. Shaw, and M. B. A. Oldstone1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol 68:6103-6110.
36. Bos, J. D., E. A. Wierenga, J. H. S. Smitt, F. L. van der Heijden, and M. L. Kapsenberg. 1992. Immune dysregulation in atopic eczema. Arch. Dermatol. 128:1509-1512.
37. Bradding, P., I. H. Featber, S. Wilson, P. G. Wardin, C. H. Heusser, S. T. Holgate, and P. H. Howarth. 1993. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. J. Immunol 151:3853-3865.
38. Bretscher, P. A. 1992. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol. Today 13:342-345.
39. Bretscher, P. A., G. Weig, J. M. Menon, and H. Bielefeldtt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542.
40. Brinkmann, V., T. Geiger, S. Alkan, and C. H. Heusser. 1993. Interferon-alpha increases the frequency of interferon-gamma producing human CD4+ T cells. J. Exp. Med. 178:1655-1663.
41. Brod, S. A., D. Benjamin, and D. A. Haflrer. 1991. Restricted T-cell expression of IL-2IFNgamma mRNA in human inflammatory disease. J. Immunol. 147:810.
42. Broide, D. H., M. M. Paine, and G. S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte-macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90: 1414.
43. Brummer, E., E. Castaneda, and A. Restrepo. 1993. Paracoccioidomycosis: an update. Clin. Microbiol. Rev. 6:89-117.
44. Brummer, E., L. H. Hanson, and D. A. Stevens. 1993. IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304). Cell. Immunol. 149:258-267.
45. Brunds, M. J., L. Luistro, and R. R. Warrier. 1993. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med. 178:1223.
46. Bullock, W. E. 1995. Histoplasma capsulatum, p. 2340-2353. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practices of infectious diseases, 4th ed. Churchill-Livingstone, New York.
47. Burdin, N., C. Peronne, J. Banchereau, and F. Rousset. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin-10. J. Exp. Med. 177:295-304.
48. Burton, J. D., R. N. Bamford, C. Paters, A. J. Grant, G. Kurys, C. K. Geldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. A lympbokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4935-4939.
49. Capron, A., and J.-P. Dessaint. 1992. Immunological aspects of schistosomiasis. Annu. Rev. Med. 43:209-218.
50. Capron, M., and A. Capron. 1994 Immunoglobulin E and effector cells in schistosomiasis. Science 264:1876-1877.
51. Caruso, A., C. Bonfanti, D. Colombrita, M. de Francesco, C. de Range, I. Foresti, F. Gargiulo, R. Gonzales, G. Gribaudo, S. Landolfo, N. Manca, M. Manni, F. Piraldi, P. Pollara, G. Ravizzola, G. Scura, L. Turlenghi, E. Viani, and A. Turano. 1990. Natural antibodies to IFN-gamma in man and their increase during viral infection. J. Immunol. 144:685-690.
52. Carvahlo, E. M., O. Bacellar, O. Brownell, T. Regis, R. L. Coffman, and S. G. Reed. 1994. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol- 152:5949-5956.
53. Carvalho, E. M., R. Badaro, S. G. Reed, W. D. Johnsen, and T. C. Jones. 1985. Absence of gamma Interferon and interleukin 2 production during active visceral leishmaniasis. J. Ciln Invest 6:2066-2069.
54. Cassatella, M. A., L. Meda, S. Gasperini, A. D'Andrea, X. Ma, and G. Trinchierl 1995. Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25:1-5.
55. Chang, T.-L., C. M. Shea, S. Urioste, R. C. Thompson, W. H. Boom, and A. K. Abbas. 1990. Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2 and IL-4 producing (Th1 and Th2) clones to an̄tigens presented by different accessory cells. J. Immunol. 145:2803-2808.
56. Chang, Y., E. Cesarinan, and M. S. Pessin. 1994. Identification of herpesvirus-like DNA sequence in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
57. Chase, M. W. 1945. The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc. Soc. Exp. Biol. Med. 59:134-135.
58. Chehimi, J. I. Frank, X. Ma, and G. Trinchieri. 1995. Differential regulation of IL-10 and role of IL-12 during HIV-infection of T helper cells, abstr. 408. In Second National Conference on Human Retroviruses. Infectious Diseases Society of America, Alexandria, Va.
59. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
60. Chehimi, J., S. E. Starr, I. Frank, M. Rengaraju, S. J. Jackson, C. Llanes, M. Kobayashi, B. Perussia, D. Young, E. Nickdarg, S. F. Wolf, and G. Trinchieri. 1992. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:789-796.
61. Chehimi, J., and G. Trinchieri. 1994. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149-161.
62. Chomarat, P., M.-C. Rissoan, J. Bancheran, and P. Miossec. 1993. Interferon-gamma inhibits interleukin 10 production by monocytes. J. Exp. Med. 177:523-527.
63. Chougnet, C., T. A. Wynn, M. Clerici, A. L. Landay, H. A. Kessler, J. Rusnak, G. P. Melcher, A. Sher, and G. M. Shearer. 1996. Molecular analysis of decreased interleukin-12 production in individuals infected with the human immunodeficiency virus. J. Infect Dis. 174:46-53.
64. Clemons, K. V., E. Brummmer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifurigal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460-464.
65. Clerici, M., J. A. Berzofsky, J. Abrams, et al. 1994. Role of interleukin-10 (IL-10) in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus (HIV-1). J. Clin. Invest. 93:768-775.
66. Clerici, M., E. Ferrario, D. Trabattoni, S. Viviani, V. Bonfanti, G. M. Shearer, and M.-L. Villa. 1994. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease: correlation of interleukin-2 production with hematologic parameters. Eur. J. Cancer 30:1464-1470.
67. Clerici, M., F. T. Hakim, D. J. Venzon, S. P. Blatt, C. W. Hendrix, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin 2 and interleukin 4 production in asymptomatic, HIV-seropositive individuals. J. Clin. Invest. 91:759-765.
68. Clerici, M., D. R. Lucey, I. A. Pinto, J. A. Berzofsky, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell mediated immune responses by interleukin-12 in vitro. Science 262:1721-1724.
69. Clerici, M, A. Sarin, J. A. Berzofsky, A. I. Landay, H. A. Kessler, C. W. Hendrix, S. P. Blatt, R. L. Coffman, P. A. Henkart, and G. M. Shearer. Antigen-stimulated apoptotic T cell death in HIV infection is selective for CD4+ T-cells, regulated by cytokines and effected by lymphotoxin. AIDS, in press.
70. Clerici, M., A. Sarin, R. L, Coffmann, T. A. Wynn, S. P. Blatt, C. W. Hendrix, S. F. Wolf, G. M. Shearer, and P. A. Henkart. 1994. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus, pathogenesis. Proc. Natl. Acad. Sci USA 91:11811-11815.
71. 71: Clerici, M., and G. M. Shearer. 1993. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107-111.
72. Clerici, M., and G. M. Shearer. 1994. The TH1/TH2 hypothesis of HIV infection: new insights. Immunol. Today 15:575-581.
73. Clerici,M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. C. Bernstein, D. C. Mann, G. M. Shearer, and J. A. Berzofsky. 1989. Interlekin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (London) 339:383-385.
74. Clerici, M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via, and G. M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients: independence of CD4 cell number and clinical staging. J. Clin. Invest. 84:1892-1899.
75. Cogan, E., L. Schandene, A. Crusiaux, P. Cochaux, T. Velu, and M. Goldman. 1994. Brief report. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N. Engl. J. Med. 336:535-538.
76. Connors, M., N. A. Giese, A. B. Kullkarni, C.-Y. Firestone, H. C. Morse III, and B. R. Murphy. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10 J. Virol 68:5321-5325.
77. Conway, B., P. Baskar, L. J. Bechtel, J. C. Kaplan, M. S. Hirsch, R. T. Schooley, and S. H. Pincus. 1992. Eosinophils as host cells for HTV-1. Arch. Virol. 127:373-377.
78. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. A. Orme. 1993. Disseminated tuberculosis in interferon gamma genedisrupted mice. J. Exp. Med. 178:2243-2247.
79. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501-507.
80. Cosentino, G., E. Soprana, C. P. Thienes, A. G. Siccardi, G. Viale, and D. Vercelli. 1995. IL-13 down-regulates CD14 expression and TNF-aipha secretion in normal human monocytes. J. Immunol. 155:3145-3151.
81. Cosman, D., D. M. Andersen, K. H. Grabstein, et al. 1994. IL-15, a novel T-cell growth factor, that shares some components of the receptor for IL-2, p. 79-86. In S. Romagnani, G. Del Prete, and A. K. Abbas (ed.). Challenges of modern medicine, vol. 8. Cytokines: basic principles and practical applications. Ares-Serano Symposia Publications, Rome.
82. Coyle, A. J., F. Erard, C. Bertrand, S. Walti, H. Pircher, and G. Le Gros. 1995. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J. Exp. Med. 181:1229-1233.
83. Dannenberg, A. M. 1991. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12:228-232.
84. Dannenberg, A. M. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. 28:33-39.
85. De Carli, M., M. M. D'Elias, S. Marietti, C. Marcocci, A. Pinchera, M. Ricci, and S. Romagnani. 1993. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J. Clin. EndocrinoL Metab. 77:1120-1124.
86. Defrance, T., P. Carayon, G. Billian, J.C. Guillemot, A. Minty, D. Capnt, and P. Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med, 179:135-143.
87. De Jong, R., M. Brouwer, B. Hooibrink, T. Van der Pouw-Kraan, F. Miedema, and R. A. W. Van Lier. 1992. The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic Stimulation in vivo. Eur. J. Immunol. 22:993-999.
88. Del Pozo, V., B. De Andres, E. Martin, B. Cardaba, J. C. Fernandez, S. Gallardo, P. Tramon, F. Leyva-Cobian, P. Palomino, and C. Lahoz. 1992. Eosinophils as antigen-presenting cells: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur. J. Immunol. 22: 1919-1925.
89. Del Prete, G., M. De Carli, F. Almerigogna, C K. Daniel, M. M. D'Elios, G. Zancuoghi, F. Vinante, G. Pizzelo, and S. Romagnani. 1995. Preferential expression of CD30 by human CD4+ T-cells producingTh2-type cytokines. FASEB J. 9:81-86.
90. Del Prete, G. F., M. De Carli, F. Almerigogna, M. G. Guidizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper T clones and type 2 helper T clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353-360.
91. Del Prete, G. F., M. De Carli, and M. D'Elios. 1993. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23:1445-1449.
92. Del Prete, G. F., M. De Carli, C. Mastomauro, R. Biagotti, D. Macchia, P. Falagiani, M. Rieci, and S. Romagnani. 1991. Purified protein derivative of mycobacteria tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human. T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346-350.
93. Del Prete, G. F., M. De Carli, M. Rieci, and S. Romagnani. 1991 Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J. Exp. Med. 174:809-813.
94. Del Prete, G. F., E. Maggi, G. Pizzolo, and S. Romagnani. 1995. CD30, Th2 cytokines and HIV infection: a complex and fascinating link Immunol. Today 16:76-80.
95. Del Prete, G., E. Maggi, and R. Romagnani. 1994. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab. Invest. 70:299-306.
96. Del Prete, G. F., A. Tiri, and M. De Carli. 1989; High potential to tumor necrosis factor-alpha production of thyroid infiltrating T lymphocytes in Hashimoto's thyroiditis: a peculiar feature of destructive thyroid autoimmunity. Autoimmunity 4:267.
97. Del Prete, G. F., A. Tiri, E. Maggi, M. De Carli, D. Macchia, P. Parronchi, M. E. Rossi, M. C. Pietrogrande, M. Ricci, and S. Romagnani. 1989. Defective in vitro production of gamma-interferon and tumor necrosis factor alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome. J. Clin. Invest 84:1830-1835.
98. Denis, M. 1991. Tumor necrosis factor and granulocyte-macrophage-colony stimulating factor stimulate human macrophages to restrict growth of Virulent Mycobacterium avium and to kill M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49:380-387.
99. Des Prez, R. M., and C. R. Heim. 1990. Mycobacterium tuberculosis, p. 1877-1907. In G. L. Mandell, R. G. Douglass, and J. E. Bennett (ed.), Principles and practices of infectious diseases, 3rd ed. Churchill Livingstone, New York.
100. Desrenmaux, P., A. Janin, J. F. Colombel, et al. 1992. Interleukin-5 mRNA expression by eosinophils in the intestinal mucosa of patients with coeliac diseases. J. Exp. Med. 175:293.
101. Desreumaux, P., A. Janin, S. Dubucqnoi, M.-C. Copia, G. Torpier, A. Capron, M. Capron, and I, Prin. 1993. Synthesis of interleukin 5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82: 1553-1560.
102. Devergne, O., D. Emilie, and M. Peuchmaur. 1992. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 and inierferon-gamma genes. Hum. Pathol. 23:317-323.
103. De Waal Malefyt, R., C. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. De Vries. 1993. Effects of IL-13 on phenotype. cytokine production and cytotoxic function of human monocytes: comparison to IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 151:6370-6381.
104. De Waal Malefyt, R. J. Haanen, H. Spits, M. G. Roncarolo, A. Te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
105. Dolan, M. J., M. Clerici, S. P. Blatt, C. W. Hendrix, G. P. Melcher, R. N. Boswell, T. M. Freeman, W. Ward, R. Hensky, and G. M. Shearer. 1995. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J. Infect Dis. 172:79-87.
106. Dooley, D. P., R. A. Cox, K. L. Hestilow, M. J. Dolan, and D. M. Magee. 1994. Cytokine induction in human coccidioidomycosis. Infect. Immun. 62:3980-3983.
107. Drabick, J. J., A. J. Magill, K. J. Smith, T. B. Nutman, and P. M. Benson. 1994. Hypereosinophilic syndrome associated with HIV infection. South. Med. J. 87:525-529.
108. Dugas, B., M. D. Mossalayi, C. Damais, and J.-P. Kolb. 1995. Nitric oxide production by human monocytes: evidence for a role of CD23. J. Immunol. 16:574-580.
109. Darun, S. K., and J. J. Oppenheim. 1993. Proinflammatory cytokines and immunity, p. 812-824. In W. E. Paul (ed.), Fundamental immunology, 3rd ed. Raven Press, New York.
110. Dvorak, A. M., R. I. Tepper, P. F. Weller, E. S. Morgan, P. Estrella, R. A. Monahan-Earley, and S. Galli. 1994. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 83:3600-3612.
111. Edwards, L. B., F. A. Acquavia, V. T. Livesay, F. W. Cross, and C. E. Palmer. 1969; AB atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am. Rev. Respir. Dis. 99(4):1-23.
112. Ellis, T. M., P. E. Simms, D. J. Slivnick, H.-M. Jack, and R. I. fisher. 1994. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J. Immunol. 151:2380-2389.
113. Elson, L. H., M. Calvopina, W. Paredes, et al. 1995. Immunity to onchocerciasis: putative immune individuals produce a Th1-like response to Onchocerca volvulus. J. Infect. Dis. 171:652-659.
114. 114: Elson, L. H, T. B. Nutman, D. D. Metcalfe, and C. Prussin. 1995. Flow cytometric analysis for cytokine production identifies Th1, Th2, and TK0 cells within the human CD4+ CD27- lymphocyte subpopulation. J. Immunol 154:4294-4301.
115. Elson, L. H., S, Shaw, R. A. W. Van Lier, and T. B. Nutman. 1994. T cell subpopulation phenotypes in filarial infections: CD27 negativity defines a population greatly enriched for Th2 cells. Int Immunol. 6:1003-1009.
116. Enokihara, H., T. Koike, H. Arimura, M. Aoyagi, K. Watanabe, Y. Nakamura, K. Yamashiro, N. Tsuruoka, M. Tsujimoto, K. Saito, S. Furusawa, and H. Shishido. 1994. IL-5 mRNA expression in blood lymphocytes from patients with Kimura's disease and parasitic disease. Am. J. Hematol. 47: 69-73.
117. Erard, F., M. T. Wild, J. A. Gareia-Sanchez, and G. Le Gros. 1993. Switch of CD8 T cells to noncytotylic CD8- CD4- cells that make Th2 cytokines and help B cells. Science 260:496-497.
118. Evans, T., L. Thai, D. L. Granger, and J. B. Hibbs. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151:907-915.
119. Fahey, J. L., J. M. G. Taylor, R. Detels, B. Hofmann, R. Melmed, P. Nishanian, and J. V. Giorgi. 1990. The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N. EngL J. Med. 322:166-172.
120. Falini, B., S. Pileri, G. Pizzolo, et al 1995. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1-14.
121. Ferrari, C., M. U. Mondelli, A. Penna, F. Fiaccadori, and F. V. Chisari. 1987. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific T helper lines. J. Immunol. 139:539-544.
122. 122: Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hseih, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma-delta T cells in vivo. Nature (London) 373:255-257.
123. Field, E. H., R. J. Noelle, T. Rouse, J. Goeken, and T. Waldschmidt. 1993. Evidence for excessive Th2 CD4+ subset activity in vivo. J, Immunol. 151:48-59.
124. Finkel T. H., G. Tudor-Williams, and N. K. Banda. 1995. Apoptosis occurs predominantly in bystander cells and not productively infected cells of HIV-and SIV-infected lymph nodes, Nat Med. 1:129-134.
125. Finkelman, F. D., K. B. Madden, A. W. Cheever, I. M. Katona, S. C. Morris, M. K. Gately, B. R. Hubbard, W. C. Gause, and J. F. Urban. 1994. Effects of IL-12 on immune responses and host protection in mice infected with intestinal nermatode parasites. J. Exp. Med. 179:1563.
126. Finotto, S., I. Ohno, J. S. Marshall, J. Gauldie, J. A. Denburg, J. Dolovich, D. A. Clark, and M. Jordana. 1994. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyps). J. Immunol. 153:2278.
127. Fitch, F. W., D. W. Lancki, and T. F. Gajewski. 1993. T-cell-mediated immune regulation, p. 733-756- In W. E. Paul (ed.), Fundamental immunology, 3rd ed. Raven Press, New York.
128. Fitzgerald, T. J. 1992. The Th1/Th2-like switch in syphilitic infection: is it detrimental? Infect, Immun. 60:3475-3479.
129. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
130. Foli, A., M. W. Saville, M. W. Baseler, and R. Yarchoan. 1995. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 85:2114-2123.
131. Fowler, D. H., and R. E. Gress. Graft-vs-host disease as a Th1-type process: regulation by donor cells of Th2 cytokine phenotype. In S. Burakoff, H. J. Deeg, J. Ferrara, and K. Atkinson (ed.), Graft-vs-host disease: immunology, pathophysiology, and treatment, 2nd ed., in press. Marcel Decker, Inc., New York.
132. Freedman, A. R., F. M. Gibson, S. C. Fleming, C. J. Spry, and G. E. Griffin. 1991. Human immunodeficiency virus infection of eosinophils in human bone marrow cultures. J. Exp. Med. 174:1661-1664.
133. Frei, K., D. Nadal, H.-W. Pfister, and A. Fontana. 1993. Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J. Exp. Med. 178:1255-1261.
134. Gallardo, S., V. Del Pozo, B. Cardaba, B. de Andres, E. Martin-Orozco, J. C. Fernandez, P. Tramon, M. Posada, I. Abaitua, P. Palamino, and C. Lahoz. 1994. Immunological basis of toxic oil syndrome (TOS). Toxicology 93:289-299.
135. Gallin, J., J. M. Farber, S. M. Holland, and T. B. Nutman. 1995, Interferon-gamma in the management of infectious diseases. Ann. Intern. Med. 123: 216-224.
136. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1792-1796.
137. Getsy, J. A., and S. M. Phillips. 1994. Cytokines in polymyalgia and giant cell arteritis. Ann. Intern. Med. 121:536-537.
138. Ghalib, H. W., M. R. Piuvezam, Y. A. W. Skeiky, M. Siddig, F. A. Hashim, A. M. EI-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest 92:324.
139. Gillis, P. S., Y. Naidu, S. Nakamura, Z. Salahuddin, and R. C. Gallo. 1991. IL-6 regulation by steroid hormones and autocrine activiry in Kaposils sarcoma. AIDS Res. Hum. Retroviruses 7:220.
140. Giorgio, J. V., J. L. Fahey, D. C. Smith, L. E. Hultin, H.-L. Cheng, R. T. Mitsuyasu, and R. Detels. 1987. Early effects of HIV on CD4 lymphocytes in vivo. J. Immunol 138:3725-3730.
141. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shorebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822-2830.
142. Gold, K. N., C. M. Weyand, and J. J. Gorozny. 1994. Modulation of helper T-cell function by prostaglandins. Arthritis Rheum. 37:925-933.
143. Golding, B., M. Zaitseva, and H. Golding. 1994. The potential for recruiting immune responses toward type 1 or type 2 help. Am. J. Trop. Med. Hyg. 50(Suppl.):33-40.
144. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Giri 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-967.
145. Graham, B. S., L. A. Bunton, P. F. Wright, and D. T. Karzon. 1992. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88:1026-1033.
146. Graham, B. S., G. S. Henderson, Y. W. Tang, X. Lu, K. M. Neuzil, and D. G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
147. Graziosi, C., G. Pantaleo, K. R. Ganett, J. F. Demarest, O. J. Cohen, and A. S. Fauci. 1994. Constitutive expression of cytokines in lymphoid tissue of HIV-infected individuals: lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265:248-252.
148. Green, S. J., and C. A. Nacy. 1993. Antimicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Curr. Opin. infect. Dis. 6:384-395.
149. Grewe, M., K. Gyufko, E. Schopf, and J. Krutmann. 1994. Lesional expression of interferon-gamma in atopic eczema. Lancet 343:25-26.
150. Grieco, M. H. 1969. Immunoglobulins and hypersensitivity in human immunodeficiency (HIV) infection. J. Allergy Clin. Immunol. 84:1-4.
151. Griffin, D. E., and B. J. Ward. 1993. Differential CD4 T cell activation in measles. J. Infect. Dis. 168:275-281.
152. Haanen, J. B. A. G., R. de Waal Malefijt, P. C. M. Res, E. M. Kraakman, T. H. M. Ottenhoff, R. R. P. de Vries, and H. Spits. 1991. Selection of a human T helper type-1 like T cell subset by mycobacteria. J. Exp. Med. 174:583-592.
153. Hall, C. B. 1994. Prospects for a respiratory syncytial virus vaccine. Science 265:1393-1394.
154. Haluska, F. G., A. M. Brufsky, and G. P. Canellos. 1994. The cellular biology of the Reed-Sternberg cell. Blood 84:1005-1019.
155. Hamid, Q., J. Barkans, S. Ying, J. S. Abrams, A. B. Kay, and R. Moqbel. 1992. Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood 80:1496-1501.
156. Hansel, T. T., J, B, Braunstein, C. Walker, K. Blaser, P. L. B. Bruijazeel, J.-C. Virchow, and C. Virchow. 1991. Sputum eosinophils from asthmatics express ICAM-I and HLA-DR. clin. Exp- Immunol. 86:271-277.
157. Hansel, T. T., J. M. De Vries, J. M. Carballido, et aL 1992. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J. Immunol. 49:130-2136.
158. Hansen, M. B., M. Svenson, M. Diamant, C. Ross, and K. Bendtzen. 1995. Interleukin-6 (IL-6) autoantibodies and blood IL-6 measurements- Blood 85:1145.
159. Hata, H., H. Xiao, M. T. Petrucci, J. Woodliff, R. Chang, and J. Epstein. 1993. Interleukin-6 gene expression in multiple myeloma; a characteristic of immature tumor cells. Blood 81:3357-3364.
160. Heinzel, F. P. 1995. Th1 and Th2 cells in the cure and pathogenesis of infectious diseases. Curr. Opin. Infect. Dis. 8:151-155.
161. Heiss, M. M., W. Mempel, K.W. Jauch, C. Delanoff, G. Mayer, M. Mempel, H.-J. Eissner, and F.-W. Schildberg. 1993. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 342:1328-1333.
162. Her, E., J. Frazer, K. F. Austen, and W. F. Owen. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. J. Clin. Invest 88:1982-1987.
163. Hernandez-Pando, R, and G. A. W. Rook. 1994. The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 83:591-595.
164. Hibbs, J. B, C. Westenfeldere, R. Taintor, Z. Vavrin, C. Kablitz, R. L. Baranowski, J. H. Ward, R. L. Menlove, M. P. McMurry, J. P. Kushner, and W. E. Samlowski. 1992. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest, 89:867-877.
165. Hilkens, C. M. U., H. Vermeulen, R. J. J. van Neerven, F. G. M. Snijdewint, E. A. Wierenga, and M. L. Kapsenberg. 1995. Differential modulation of T helper type 1 (Th1) and T helper 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25:59-63.
166. Hilleman, M. R. 1994. Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventive against AIDS. AIDS Res. Hum. Retroviruses 10:3-12.
167. Hillman, G. G., E. Younes, D. Visscher, E. Ali, J. S. Lam, E. Montecillo, J. E. Pontes, G. P. Haas, and R. K. Puri. 1995. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model. Cell. Immunol. 166:257-263.
168. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487-495.
169. Holland, S. M., E. M. Eisenstein, D. B. Kuhns, M. L. Turner, T. A. Fleisher, W. Strober, and J. I. Gallin. 1994. Treatment of refractory non-tuberculous mycobacterial infection with interferon gamma. N. Engl. J. Med. 330:1348-1355.
170. Holt, P. G. 1994. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 344:456-458.
171. Hostetler, J. S, E. Brummer, R. L. Coffman, and D. A. Stevens. 1993. Effects of anti-IL-4, interferon-gamma and an antifungal triazole (CSH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome. Clin. Exp. Immunol. 94:11-16.
172. Howard, M. C., A. Miyajima, and R. Coffmann, 1993. T-cell-derived cytokines and their receptors, p. 763-800. In W. E. Paul (ed.), Fundamental immunology, 3rd ed. Raven Press, New York.
173. Hseih, C.-S., S. E. Macatonia, C S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
174. Huang, S.-K., H.-Q. Xiao, J. Kleine-Tebbe, G. Paciotti, D. G. Marsh, L. M. Lichtenstein, and M. C. Lin. 1995. IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 155:2688-2694.
175. Hughes, H. P. A., and L. A. Babiuk. 1994. Potentiation of vaccines through effective adjuvant formulations and manipulation of the immune response, p. 87-118. In E. Kurstak (ed.), Modern vaccinology, vol. 5. Plenum Medical, New York.
176. Hunt, N. C. A., and R. D. Goldin. 1992. Nitric oxide production by monocytes in alcoholic liver disease. J. Hepatol. 14:146-150.
177. Israel-Biet, D., F. Labrousse J.-M. Tourani, H. Sors. J.-M. Adrieu,and P. Even. 1992. Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. J. Allergy Clin. Immunol. 89:68-75.
178. Kadin, M., J, Butmare, A. Elovic, and D. Wong. 1993. Eosinophils are the major source of transforming growth factor-ß 1 in nodular sclerosing Hodgkin's disease. Am. J. Pathol. 142:11-16.
179. Karp, C. L., S. H. El-Safi, T. A. Wynn, M. M. H. Satti, A. M. Kordofani, F. A. Hashim, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In vivo cytokine profiles in patients with kala-azar. J. Clin. Invest. 91:1644-1648.
180. Karupiah, G, Q.-W. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-1448.
181. Katamura, K, N. Shintakn, Y. Yamauchi, T. Fukui, Y. Ohshma, M. Mayumi, and K. Furusho. 1995. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and EL-2, but not IL-4 and IL-5. J. Immunol. 155:4604-4612.
182. Katsikas, P. D., C.-Q. Chu, F. M. Brennaa, R. N. Maini, and M. Feldmann. 1994. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179:1517-1527.
183. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoka, B. Tang, O. Tanabe, H. Tanaka, A. Kuramoto, and T. Kishimoto. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature (London) 332:83-85.
184. Kay, A. B. 1994. Origin of type 2 helper T cells. N. Engl. J. Med. 30:567-569.
185. Kay, A. B., S. Ying, M. Varney, M. Gaga, S. R. Durbam, R. Meqbel, A. J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4, IL-5 and GM-CSF in allergen induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:775-778.
186. Kemp, M., J. A. L. Kurtzhals, K. Bendtzen, L. K. Ponlsen, M. B. Hansen, D. K. Koech, A. Kharazami, and T. G. Theander. 1993. Leishmania denovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect. Immun. 61:1069-1073.
187. Kennedy, M. K., K. S. Picha, K. D. Shanebeck, D. M. Anderson, and K. H Grabstein. 1994. Interleukin-12 regulates the proliferation of Th1, bat'not Th2, or Th0, clones. Eur. J. Immunol 24:2271-2278.
188. Kim, J, R. L. Modlin, R. L. Moy, S. M. Dubinett, T. McHugh, B. J. Nickoloff, and K. Uyemura. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas. J. Immunol. 155:2240-2247.
189. King, C. L., J. L. Gallin H. L. Malech, S. L. Abramson, and T. B. Nutman. 1989. Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc. Natl. Acad. Sci. USA 86:10085-10089.
190. King, C. L., J. Hakimi, M. T. Shata, and A. Medhat. 1995. IL-12 regulation of parasite antigen-driven IgE production in human helminth infections: J. Immunol. 155:454-461.
191. King, C. L., and T. B. Natman. 1993. IgE and IgG subclass regulation by IL-4 and IFN-gamma in human helminth infections. J. Immunol. 151:458-465.
192. King, C. L., A, Otteson, and T. B. Nutman. 1990. Cytokine regulation of antigen-driven immunoglobulin production in filarial parasite infection in humans. J. Clin. Invest. 85:1810-1815.
193. King, C L., G. Thyphronitis, and T. B. Nutman. 1990. Enumeration of IgE secreting B cells. A filter spot ELISA. J. Immunol. 132:37-43.
194. Kirkly, S. A., J. Cowles, V. D. Pellegrini, C. M. Harris, A. D. Boyd, and N. Blomberg. 1995. Cytokine secretion after allogeneic or autologous blood transfusion. Lancet 345:527.
195. Kitsukawa, IC, A. Nakamoto, H. Koito, Y. Matsuda, A. Saito, and H. Yamameto. 1995. Interferon-gamma production by human T lymphocytes upon Legionella pneumophila stimulation in vitro. Clin. Exp. Immunol. 99:76-81.
196. Klein, B., X.-G. Zhang, Z.-Y. Lu, and R- Bataille. 1995. Interleukm-6 in human multiple myeloma. Blood 85:863-872.
197. Kline, J. N., and G. W. Hunninghake. 1994. T-lymphocyte dysregulation in asthma. Proc Soc. Exp. Biol. Med. 207:243-253.
198. Knutsen, A. P., K. R. Mueller, A. D. Levine, B. Chouhan, P. S. Hutcheson, and R. G. Slavin. 1994. Asp f I CD4+ Th2-like T-cell lines in allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol, 94:215-221.
199. Koup, R. A., and D. D. Ho. 1994. Shutting down HIV. Nature (London) 370:416.
200. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C Farthing and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
201. Kovacs. J. A., M. Baseler, R. Dewar, S. Vogel, R. T. Davey, J. Falloon, M. A. Polis, R. E. Walker, R. Stevens, N. P. Salzman, J. A. Metcalf, H. Masur, and H. C Lane. 1995. Sustained increases in CD4+ lymphocytes in HIV-infected patients treated with intermittent interleukin-2 therapy. N. Engl. J. Med. 332:567-575.
202. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 89:707-718.
203. Kurup, V. P., B. W. P. Seymour, H. Choi, and R. L. Coffman, 1994. Particulate Aspergillus fumigatus antigens elicit a Th2 response in BALB/c mice. J. Allergy Clin, Immunol. 93:1013-1020.
204. Lahesmaa, R., H. Yssel, S. Batsford, R. Lunkkainen, T. Mottonen, L. Steinman, and G. Peltz. 1992. Yersimia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J. Immunol 148:3079-3085.
205. Lai, K. N. N., R. T. H. Ho, C. K. W. Lai, C. H. S. Chan, and P. K. T. Li. 1994. Increase of both circulating Th1 and Th2 lymphocyte subsets in IgA nephropathy. Clin. Exp. Immunol. 96:116-121.
206. Lander, H. M-, P. Sehajpal, D. M. Levine, and A. Novogrodsky. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509.
207. Lane, H. C, H. Maser, L. C. Edgar. G. Whalen, A. H. Rook, and A. S. Fanci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453-458.
208. Leonard, J. P., K. E. Waldhurger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encophalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381-386.
209. Leung, D. Y. M., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon-gamma gene expression in steroid-resistant asthma. J. Exp. Med 181:33-40.
210. Liblau, R. S., S. M. Singer, and H. O. MeDevitt. 1995. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34-38.
211. Liles, W. C., and C. Van Voorhis. 1995. Nomenclature and biologic significance of cytokines involved in inflammation and file host immune response. J. Infect. Dis. 172:1573-1580.
212. Limaye, A. P., J. S. Abrams, J. E. Silver, E. A. Ottesen, and T. B. Nutman. 1990. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J. Exp. Med. 172: 399-402.
213. Lin, H., T. R. Mosmann, L. Guilbert S. Tuntipopat, and T. G. Wegmann. 1993. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol 151:4562-4573.
214. Llorente, L., Y. Richaund-Patin, J. Fior, J. Alcocer-Vareta, J. Wijdenes, Morel-Fourrier, P. Galanaud, and D. Emilie. 1994. In vivo production of interleukin-10 by non-T-cells in rheumatoid artbritis, Sjogren's syndrome, and systemic lipus erythematous: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 37:1647-1655.
215. Llorente, L., W. Zon, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Aleocer-Varela, B. Morel-Fourrier, J. C. Brouet, D. Alaroon-Segovia, P. Galanaud, and D. Emilie. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839-844.
216. Locksly, R. M. 1993. Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90:5879-5880.
217. Locksley, R. M. 1994. Th2 cells: help for helminths. J. Exp. Med. 179:1405-1407.
218. Locksley, B. M., and C B. Wilson. 1995. Cell-mediated immunity and its role in host defense, p. 102-149. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.). Basic principles in the diagnosis and management of infectious diseases, 4th ed. Churchill Livingstone, New York.
219. Lucey, D. R., M. Clerici, and G. M. Shearer. 1995. Lymphocyte and monocyte functional assays, p. 2124-2140. In T. Fleisher, R. R. Rieb, B. D. Schwanz, W. T. Shearer, and W. Strober (ed.), Clinical immunology principles and practices. Mosby Yearbook, Inc., St. Louis.
220. Lucey, D. R., D. I. Dorsky, A. Nicholson-Weller, and P. F. Welter. 1989. Human eosinophils express CD4 protein and bind human immunodeficiency virus gp120. J. Exp. Med. 169:327-332.
221. Lucey, D. R., C. Hendrix, C. Andrzejewski, G. P. Melcher, C. A. Butzio, R. Henry, F. H. Wians, and R, N. Boswell. 1992. Comparison by race of total serum IgG, IgA and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1. J. Acquired Immune Defic. Syndr. 5:325-332.
222. Lucey, D. R, and J. H. Maguire. 1993. Schistosomiasis. Infect, Dis. Clin. North Am. 7:635-655.
223. Lucey, D. R., S. A. MeGuire, S. Abbadessa, K. Hall, B. Woolford, C. Butzin, G. P. Melcher, and C. W. Hendrix. 1993. Cerebrospinal fluid neopterin fluid levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HlV-1): relationship to immune status. Viral Immunol. 6:267-272.
224. Lucey, D. R., S. A. McGuire, M. Clerici, K. Hall, J. Benton, C. A. Butzin, W. W. Wart, G. Shearer, R. N. Boswell, and C W. Hendrix. 1991. Comparison of spinal fluid ß2-microglobulin levels with CD4+ T-cell, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1. J. Infect. Dis. 163:971-975.
225. Lucey, D. R., G. P. Meleher, C. W. Hendrix, R. A. Zajac, D. W. Goetz, C. A. Buttin, M. Clerici, R. D. Warner, S. Abbadessa, K. Hall, R. Jaso, B, Woolford, S. Miller, N, L Stocks, C. M. Salinas, W. H. Wolfe, G. M. Shearer, and R. N. Boswell. 1991. Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T-cell counts. J. Infect. Dis. 164:631-637.
226. Lucey, D. R.,A. Nicholson-Weller, and P. F. Weller. 1989. Mature human eosinophils have the capacity to express HLA-DR. Proc. Natl. Acad. Sci. USA 86:1348-1351.
227. Lucey, D. R., L. A. Pinto, F. R. Bethke, J. Rusnak, G. P. Melcher, F. N. Hashemi, A. L. Landay, H. A. Kessler, R. J. Paxton, K. Grabstein, and G. M. Shearer. Immunologic and virologic effects .of IL-15 on peripheral blood mononuclear cells from HIV-infected patients. Submitted for publication.
228. Lucey, D. R., and G. M. Shearer. 1995. Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. Lancet 345:919-920. (Letter.)
229. Lucey, D. R., R. A. Zajac, G. P-Melcher, C. A. Butzin, and R. N. Boswell. 1990. Serum IgE levels in 622 persons with human immunodeficiency virus infection: IgE elevation with marked depletion of CD4+ T-cells. AIDS Res. Hum. Retroviruses 6:427-429.
230. MacGlashan, D., J. M. White, S.-K. Huang, S. J. Ono, J. T. Schroeder, and L. M. Lichtenstein. 1994. Secretion of IL-4 from human basophils. J. Immunol 152:3006-3012.
231. Maggi, E., P. Biswas, G. Del Prele, P. Parronchi, D. Macchia, C. Simoaelli, L. Emmi, M. De Carli, A. Tiri, M. Ricci, and S. Romagnani. 1991. Accumulation of Th2-like helper cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 146:1169-1174,
232. Maggi, E., R. Giudizi, F. Biagiotti, F. Annonziato, R. Manetti, M.-P. Piccinni, P. Parronichi, S. Sampegnaro, L. Giannarini, G. Zuccati, and S. Romagnani. 1994. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180:489-495.
233. Maggi, E, A, Macchia, P. Parronchi, M. Mazetti, A. Ravina, D. Milo, and S. Romagnani. 1987. Reduced production of interleukin-2 and interferongamma and enhanced helper activity for IgG synthesis by cloned CD4+ T-cells from patients with AIDS. J. Immunol 17:1685-1689.
234. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. de Carli, M. P. Piccini, R. Manetti, M. Carbonari, A. M. Pesoe, G. del Prete, and S. Romagnani. 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244-248.
235. Mahanty, S., J. S. Abrams, C. L. King, A. P. Limaye, and T. B. Nutman. 1992. Parallel regulation of IL-4 and IL-5 in human helminth infections. J. Immunol 148:3567-3571.
236. Mahanty, S., C. L. King, V. Kumaraswami, J. Regunathan, A. Maya, K. Jayaraman, J. S. Abrams, E. A. Ottesen, and T. B. Nutman. 1993. IL-4 and IL-5 secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J. Immunol. 151:3704-3711.
237. Maizels, R. M., D. A. P. Bundy, M. E. Selkirk, D. F. Smith, and R. M. Andersen. 1993. Immunological modulation and evasion by helminth parasites in human populations. Nature (London) 365:797-805.
238. Manetti, R., F. Annunziato, R. Biagiotti, M. G. Guidizl, M.-P. Plccini, L. Giaunarini, S. Sampognaro, P. Parronchi, F. Vinante, G. Pizzolo, E. Maggi, and S. Romagnani. 1994. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+ CD30+ T cell clones in human immunodeficiency virus infection. J. Exp. Med. 180:2407-2411.
239. Manetti, R., P. Parronchi, M. G. Guidizi, M.-P. Piccinni, E. Maggi, G. Trinclieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells, J. Exp. Med. 177:1199-1204.
240. Mannhalter, J. W., M. B. Fischer, H. M. Wolf, Z. Kapcn, N. Barrett, F. Dorner, G. Eder, and M. M. Eibl. 1993. Immunization of chimpanzees with recombinant gp 160, but not infection with human immunodeficiency virus type 1, induces envelope-specific Th1 memory cells. J. Infect Dis, 171:437-440.
241. Mannick, J. B, K. Asano, K. Izumi, E. Kieff, and J. S. Stanmler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137-1146.
242. Markowitz, N., N. I. Hansen, T. C. Wilcosky, P. C. Hopewell, J. Glassroth, P. A. Kuale, B. T. Mangura, D. Osmoad, J. M. Wallace, M. J. Rosen, and L. B. Reichman. 1993. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann. Intern. Med. 119:185-193.
243. Matthews, D. J., P. A. Clark, J. Herbert, et at 1995, Function of the interleukin-2 (IL-2) receptor gamma chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85:38-42.
244. Mawhorter, S. D., J. W. Kazura, and W. H. Boom. 1994. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen and antigeninduced CD4+ T-cell proliferation. Immunology 81:584-591.
245. McDonall, W. M., and F. K. Askari. 1996. Molecular medicine: DNA vaccines. N. Engl. J. Med. 334:42-45.
246. McHugh, S. M., L R. Rifkin, J. Deighton, A. B. Wilson, P, J. Lachmann, C M. Lockwood, and P. W. Ewan. 1995. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen and antigen-stimulated human peripheral blood mononuclear cell cultures, clin. Exp. Immunol- 99:160-167.
247. McKenzie, A. N. J., J. A. Culpepper, R. De Waal Malerfyt, F. Briere, J. Punnonen, G. Averse, A. Sato, W. Dang, B. G. Cocks, S. Menon, J.E. De Vries, J. Banchereau, and G. Zurawski. 1993. Interleukin -13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 90:3735-3739.
248. Merz, H., F. A. Houssiau, K. Orscheschek, J. C. Renanld, A. Fliedner, M. Herin, H. Noel, M. Kadin, H. K. Mueller-Hermelink, J. Van Snick, and A. C. Feller. 1991. Interleukin-9 expression in human malignant lympho-mas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311.
249. Meuer, S. C., R. E. Hussey, A. C. Penta, K. A, Fitzgerald, B. M. Stadler, S. F. Schlossman, and E. L. Reinherz. 1982. Cellular origins of interleukin 2 (IL-2) in man: evidence fen- stimulus-restricted IL-2 production by T4+ and T8+ lymphocytes. J. Immunol. 129:1076-1079.
250. Meyaard, L, S. A. Otto, B. Hooibrink, and F. Miedema. 1994. Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. J. Clin. Invest 94:1947-1952.
251. Meyaard, L., S. A. Otto, L. P. M. Keet, R. A. W. van Lier, and F. Miedema. 1994. Changes in cytokine secretion patterns of CD4+ T-cell closes in human immunodeficiency virus infection. Blood 84:4262-4268.
252. Miedema, F., A. J. C. Petit, F. G. Terpstra, J. K. M. E. Schattenkerk, F. de Wolf, B. J. M. Al, M. Roos, J. M. A. lange, S, A. Danner, J. Goudsmit, and P. T. A. Schellekens. 1988. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T-helper cell depletion occurs. J. Clin. Invest. 82:1908-1914.
253. Mildvan, D., U. Mathnr, R. W. Enlow, P. L. Romain, R. J. Winchester, C. Colp, H. Singman, B. R. Adelsberg, and I. Spigland. 1982. Opportunistic infections and immune deficiency in homosexual men. Ann. Intern. Med. 96:700-704.
254. Miles, S. A. 1994. Pathogenesis of HIV-related Kaposi's sarcoma. Curr. Opin. Oncol 6:497-502.
255. Miller, S. D., and W. J. Karpos. 1994. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today 15: 356-360.
256. Miltenberg, A. M. M., J. M. Van Laar, R. De Kniper, M. R. Daha, and F. C. Breedveld. 1992. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand. J. Immunol. 35:603-610.
257. Mingari, M. C, A. Moretta, E. Maggi, G. Pantaleo, F. Gerosa, S. Romagnani, and L. Moretia. 1984. Frequent coexpression of eytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones. Eur. J, Immunol. 14:1066-1069.
258. Miyazaki, I., R. K. Cheung and H.-M.Dosh. 1994. The role of vIL 10 and other EBV latency genes early during B cell growth transformation, Semin. Virol. 5:405-414.
259. Modlin, R. L., and B. R. Bloom. 1993. Immune regulation: learning from leprosy. Hosp, Pract 28:71-84.
260. Modlia, R. L., and T. B. Nutman. 1993. Type 2 cytokines and negative immune regulation in human infections. Curr. Opin. Immunol. 5:511-517.
261. Moqbel, R., S. Ying, J. Barkans, T. M. Newman, P. Kimmitt, M. Wakelin, L. Taborda-Barata, Q. Meng, C. J. Corrigan, S. R. Durham, and A. B. Kay. 1995. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product J. Immunol. 155:4939-4947.
262. Moreno, C., and A. J. Rees. 1993. Striking the right balance: the role of cytokines in mycobacterial disease. Clin. Exp. Immunol. 94:1-3.
263. Monta, IL, and Y. Kitano. 1994. Kimura's disease with high serum levels of eosinophil cationic protein and major basic protein. Clin. Immunol. Imuopathol. 72:280-281.
264. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clones. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
265. Mosmann, T. R., and R. L. Coffman. 1987. Two types of mouse T helper cell clones: implications for immune regulation. Immunol. Today 8:223-226.
266. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
267. Mosmann, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:111-147.
268. Motoi, M., S. Wahid, Y. Horie, and T. Akagi. 1992. Kimura's disease: clinical, histological and immunohistochemical studies. Acta Med. Okayama 46:449-455.
269. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387-391.
270. Murray, H. W., and R. F. Teitlebaum. 1992. L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect Dis. 165:513.
271. Nabors, G. S., L. C. Afonso, J. P. Farrell, and P. Scott. 1995. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and-Pentostam. Proc. Natl. Acad. Sci. USA 92:3142-3146.
272. Nadbli, G., F. Vinante, A. Ambrosetti, G. Todeschini, D. Veneri, R. Zanotti, V. Meneghini, M. M. Ricetti, F. Benedetti, A. Vassanelli, G. Perona, M. Chilosi, F. Menestrina, M. Fiachini, H. Stein, and G. Pizzolo. 1994. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J. Clin. Oncol. 12:793-797.
273. Nathan, C. 1994. Nitrix oxide and biopterin: a study in chiaroscuro. J. Clin. Invest. 93:1875-1876.
274. Nathan, C. F., G. Kaplan, W. R. Levis, A. Nusrat, M. D. Witmer, S. A. Sherwin, C. K. Job, C. R. Horowitz, R. M. Steinman, and Z. A. Cohn. 1986. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N. Engl. J. Med. 315:6-15.
275. Navikas, V., J. Link, B. Wahren, C. H. Persson, and H. Link. 1994. Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor (TGF-β) mRNA expressing blood mononuclear cells in human HIV infection. Clin. Exp. Immunol. 6:59-63.
276. Newman, G. W., J. R. Guarnaccia, E. A. Vance, J.-Y. Wu, H. G. Remold, and P. H. Kazanjian. 1994. Interleukin-12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacterium avium. AIDS 8:1413-1419.
277. Nickerson, P., W. Stuerer, J. Steiger, Z. Zheng, A. W. Steele, and T. B. Strom. 1994. Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6:757-764.
278. Nonaka, M., R. Nonaka, K. Wooley, E. Adelroth, K. Mjura, P. O'Byrne, J. Delovich, and M. Jordana. 1995. Localization of interleukin-4 in eosinophils in nasal polyps and asthmatic bronchial mucosa. J. Immunol. 155: 3234-3244.
279. Ochoa, J. B., B. Curti, A. B. Peitzman, R. L. Simmons, T. R. Billiar, R. Hoffman, R. Rault, D. L. Longo, W. I. Urba, and A. C. Ochoa. 1992. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J. Natl. Cancer Inst. 84:864-867.
280. Orange, J. S., T. R. Salazar-Mather, S. M. Opal, et al. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901-914.
281. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253-1264.
282. Orscheschek K., H. Merz, J. Hell, T. Binder, H. Bartels, and A. C. Feller. 1995. Large-cell anaplastic lymphoma-specific translocation (t[2:5]) in Hodgkin's disease: indication of a common pathogenesis? Lancet 345:87-90.
283. Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wyma, E. J. Pearce, and A. Sher. 1994. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153:1707.
284. Otteson, E. A., and T. B. Nutman. 1992. Tropical pulmonary eosinophilia. Annu. Rev. Med. 43:417-424.
285. Owen, W. F., J. Petersen, D. M. Sheff, R. D. Foleerth, R. J. Anderson, J. M. Corson, A. L. Sheffer, and K. F. Austen. 1990. Hypodense eosinophils and interleukin-5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Proc. Natl. Acad. Sci. USA 87:8647-8651.
286. Paganelli, R., E. Fanales-Belasio, E. Scala, D. Carmini, I. Mezzaroma, E. Pinter, and F. Aiuti. 1991. Serum eosinophil cationic protein (ECP) in human immunodeficiency virus (HIV) infection. J. Allergy Clin. Immunol. 88:416-418.
287. Paganelli, R., E. Scala, I. J. Ansotegui, C. M. Ausiello, E. Halopi, E. Fonales-Belassio, G. D'Offizi, I. Mezzaroma, F. Pandolfi, M. Fiorilli, A. Cassone, and F. Aiuti. 1995. CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J. Exp. Med. 181:423-428.
288. Paganelli, R., E. Scala, M. R. Capobianchi, et al. 1991. Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis. Clin. Exp. Immunol. 84:28-33.
289. Paquet, P., F. Laso-Dosal, and M. de la Brassinne. 1992. Wells' syndrome: report of 2 cases. Dermatology 184:139-141.
290. Parish, C. R. 1972. The relationship between humoral and cell-mediated immunity. Transplant Rev. 13:35-66.
291. Parkin, J. M., L. J. Eales, A. R. Galazka, and A. J. Pinching. 1987. Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma. Br. Med. J. 294:1185-1186.
292. Parronchi, P., D. Macchia, M.-P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari, and S. Romagnani. 1991. Allergen and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. NatL Acad. Sci. USA. 88:4538-4542.
293. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241-251.
294. Pelliniemi, T.-T., K. Irjala, K. Mattila, K. Pulkki, A. Rajamaki, A. Tienhaara, M. Laakso, and R. Lantinen. 1995. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Blood 85:765-771.
295. Peltz, G. 1991. A role of CD4+ T-cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases. Immunol. Rev. 123:23-35.
296. Pene, J., F. Rousset, F. Briere, J. Chretien, J.-Y. Bonnefoy, H. Spits, T. Yokota, N. Arai, K.-I. Arai, J, Bancherea, and J. E. De Vries. 1988. IgE production by normal lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc. Natl Acad, Sci USA 85:880-6884.
297. Piccinni, M.-P, M.-G. Guidizi, R. Biagiotti, L. Beloni, L Giaanarini, S. Sampognaro, P. Parronchi, R. Manetti, F. Annnnzitto, C. Livi ,S. Romagnani, and E. Maggi. 1995. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155:128-133.
298. Pinto, L., J. Sullivan, J. A., Berzofsky, A. Landay;, H. Kessler, and G. M. Shearer. 1995. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest, 96:867-873.
299. Pirmez, C., M. Yamamura, K. Uyemara, M. Paes-Oliverra, F. Conceicao-Silva, and R. L. Modlin. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest, 91:1390-1395.
300. Pizzolo, G., F. Vinante, M. Chilosi, S. Romagnani, and G. Del Prete. 1994. CD30 antigen and cellular biology of Reed-Sternberg cells. Blood 84:3983-3984.
301. Pizzolo, G., F, Vinante, and L. Morosato. 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8:741-745.
302. Probst, P., E. Hermann, and B. Fleischer. 1994. Role of bacteria-specific T cells in Ae immunopathogenesis of reactive arthritis. Trends Microbiol. 2329-332.
303. Pennonen, J., G. Aversa, B. G. Cocks, A. N. J. MeKanzie, S. Menon, G. Zarawski, R. De Waal Malefyt, and J. E. De Vries. 1993. Interleukin 13 induces interleukin 4-dependent IgG4 and IgE synthesis and CD23 expresSion by human B cells, Proc. Natl. Acad. Sci. USA 90:3730-3734.
304. Quayle A. J., P. Chomarat, P. Miossec, J. Kjeldsen-Kragh, O. Forre, and J. B. Natvig. 1993. Rheumatoid inflammatory T-cefl clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand. J. Immunol. 38:75-82.
305. Qainn, T. C., P. Piot, J. B. McConniek, F. M. Feinsod, H. Taelman, B. Kapita, W. Stevens, and A. S. Fand. 1987. Serologic and immunologic studies in patients with acquired immunodeficiency syndrome in North America and Africa: the potential rote of infectious agents as cofactors in HIV infection. JAMA 257:2617-2621.
306. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levane, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatniy autoimmune disease, J. Exp. Med. 180:1961-1966.
307. Rand, T. H., W. W. Craikshank, D. M. Center, and P. F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med. 173:1521.
308. Ridley, D. S., and W. H. Jopling, 1966. Classification of leprosy
309. Riedel, D., A. Lindemann, M. Brach, R. Mertelsmann, and F. Hermann. 1990. Granulocyte-macrophage colony stimulating factor and interleukin-3 induce surface expression of interleukin-2 receptor p55-chain and CD4 by human eosinophils. Immunology 70:258-261.
310. Roberts, R. L., B. J. Ank, I. B. Salusky, and E. R. Stiehn. 1990. Purification and properties of peritoneal eosinophils from pediatric dialysis patients. J. Immunol. Methods 126:205-211.
311. Robinson, B. W. S., L. McLemore, and R. G. CrystaL 1985. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J. Clin. Invest. 75:1438-1495.
312. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopuolos, J. Barkans, A. M. Bentley, C Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
313. Rodgers, S., R. C. Rees, and B. W. Hancock. 1994. Changes in the phenotypic characteristics of eosinophils from patients receiving recombinant human interteukin-2 (rh IL-2) therapy. Br. J. Haematol. 86:746-753.
314. Romagnani, S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12:256-257.
315. Romagnani, S. 1992. Induction of Th1 and Th2 responses: a key role for the 'natural' immune response? Immunol. Today 13:379-381.
316. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
317. Romagnani, S. 1995. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:121-129.
318. Romagnani, S., E. Maggi and G-Del Prete. 1994. HIV can induce a Th1 to Th0 shift and preferentially replicates in CD4+ T-cell clones producing Th2-type cytokines. Res. Immunol. 145:611-618.
319. Romani, L., A. Menacci, L. Tennetti, R. Spaccapelo E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni, 1994. IL-12 is both required and prognostic in vivo for T helper type I differentiation in marine candidiasis. J. Immunol. 153:5167-5175.
320. Romani, L., A. Menacei, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Paccetti, and F. Bistoni. 1994. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909-915.
321. Romani, L., S. Mocci, C. Bietta, L., Lanfaloni, P. Pacceti, and F. Bistoni. 1991. Th1 and Th2 cytokine patterns in mutine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59:4647-4654.
322. Rook, A. H., M. Kubin, M. Cassin, E. C. Vonderheid, B. R. Vowels, J. T. Wolfe, S. F. Wolf, A. Singh, G. Trinchieri, and S. R. Lessin. 1995. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J. Immunol. 154:1491-1498.
323. Roos, M. T. L., F. Miedema, M. Koot, et al. 1995. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J. Infect. Dis. 171:531-536.
324. Saed, G., D. P. Flvenson, Y. Naidu, and B. J. Nickoloff. 1994. Mycosis Fungoides exhibits a Th1 type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J. Invest. Dermatol. 103:29-33.
325. Safrit, J. T., C. A. Andrews, T. Zhu, and D. D. Ho. 1994. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179: 436-472.
326. Sager, N., A. Feldmann, G. Schilling, P. Kreitsch, and C. Neumann. 1992. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J. Allergy Clin. Immunol. 89:801-810.
327. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282.
328. Salk, J., P. A. Bretscher, P. L. Salk, M. Clerici, and G. M. Shearer. 1993. A strategy for prophylactic vaccination against HIV. Science 260:1270-1272.
329. Saltini C., J. R. Spurzem, P. Pinkston, and R. G. Crystal. 1986. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset. J. Clin. Invest. 77:1962-1970.
330. Samoszuk, M. 1992. IgE in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 79:1518-1522.
331. Samoszuk, M., and L. Nansen. 1990. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13-16.
332. Sampaio, E. P., A. L. Moreira, E. N. Sarno, A. M. Malta, and G. Kaplan. 1992. Prolonged treatment with recombinant interferon-gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J. Exp. Med. 175:1729-1737.
333. Schandene, L., A. Ferster, F. Mascart-Lemone, A. Crusiaux, C. Gerard, A. Marchant, M. Lybin, T. Velu, E. Sariban, and M. Goldman. 1993.T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Ommen's syndrome). Eur. J. Immunol. 23:56-60.
334. Schauf, V., W. N. Rom, K. A. Smith, E. P. Sampaio, P. A. Meyn, J. M. Tramontana, Z. A. Cohn, and G. Kaplan. 1993. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J. Infect. Dis. 168:1056.
335. Schellenkens, P. T., M. T. Roos, F. DeWolfe, J. M. Lange, and F. Miedema. 1990. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for AIDS in HIV-infected men. J. Clin. Immunol. 10:121-127.
336. Schlaak, J., E. Hermann, M. Ringhoffer, P. Probst, H. Gallati, K.-H. M. zum Buschenfelde, and B. Fleischer. 1992. Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur. J. Immunol. 22:2771-2776.
337. Schlaak, J. F., M. Buslau, W. Jochum, E. Hermann, M. Girndt, H. Gallati, K.-H. M. zum Beschenfelde, and B. Fleischer. 1994. T cells involved in psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol. 102:145-149.
338. Schlossman, S., L. Baumsell, W. Gilks, J. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. Teddler, and R. Todd. 1995. Leukocyte typing V. Oxford University Press, Oxford.
339. Schmitz, J., M. Assenbacher, and A. Radbruch. 1993. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur. J. Immunol. 23:191.
340. Schneemann, M., G. Schoeden, S. Hofer, N. Blau, L. Guerrero, and A. Schaffer. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358-1363.
341. Schroeder, J. T., D. W. MacGlashan, A. Kagey-Sobotka, J. M. White, and L. M. Lichtenstein. 1994. IgE dependent IL-4 secretion by human basophils. J. Immunol. 153:1808.
342. Schwab,U., H. Stein, J. Gerdes, H. Lenike, H. Kirchner, M. Schaadt, and V. Diehl. 1982. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature (London) 299:65-68.
343. Schwartz, D. H., G. Skowron, and T. C. Merigan. 1991. Safety and eflects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. J. Acquired Immune Defic. Syndr. 4:11-23.
344. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496-497.
345. Secrist, H., R. H. DeKruylf, and D.T. Umetsu. 1995. Interleukin 4 production by CD4+ T-cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081-1089.
346. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-10702.
347. Seder, R. A., J. L. Boulay, F. Finkelman, S. Barbier, S. Z. Ben-Sasson, G. Le Gros, and W. E. Paul. 1992. CD8+ T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1652-1656.
348. Seder, R. A., K. H. Grabstein, J. A. Berzofsky, and J. F. McDyer. 1995. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J. Exp. Med. 182:1067-1078.
349. Seder, R. A., and G. G. Le Gros. 1995. The functional role of CD8+ T helper type 2 cells. J. Exp. Med. 181:5-7.
350. Seder, R. A., and W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673.
351. Seder, R. A., W. E. Panl, M. M. Davis, and B. Fezekas de St. Groth. 1992. The presence of interleukin 4 during in vitro priming determines the lymphocyte-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
352. Sell, S., and P.-L. Hsu. 1993. Delayed hypersensitivity, immune deviation, antigen processing and T-cell subset selection in syphilis pathogenesis and vaccine design. Immunol. Today 14:576.
353. SeImaj, K., C. S. Raine, B. Cannella, and C. F. Brosman. 1991. Identification of lymphotoxin & tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:949-953.
354. Shapshak, P., I. Nagano, K. Xin, W. Bradley, C. B. McCoy, N. C. J. Sun, R. V. Stewart, M. Yoshioka, C. Petito, K. Goodkin, R. Douyon, A. K. Srivastava, and K. A. Crandall. 1995. HTV-1 heterogeneity and cytokines: neuropathogenesis. Adv. Exp. Med. Biol. 373:225-238.
355. Shearer, G. M., D. C. Bernstein, K. S. Tang, C. S. Via, R. Redfield, S. Z. Salahuddin, and R. C. Gallo. 1986. A model for the selective loss of major histocompatibility complex restricted T-cell immune response during the development of acquired immune deficiency syndrome. J. Immunol. 137: 2514-2521.
356. Shearer, G. M., and M Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21-24.
357. Shearer, G. M., M. Clerici, and D. R. Lucey. 1994. Cytokines and HIV. Semin. Virol. 5:449-455.
358. Sher, A., and R. L. Coffmann. 1992. Regulation of immunity to parasites by T-cells and T-cell derived cytokines. Annu Rev. Immunol. 10:385-409.
359. Sher, A., R. T. Gazzinelli, I. P. Oswald, M. Clerici, M. Knllberg, E. J. Pearce, J. A. Berzofsky, T. R. Mosmann, S. L. James, H. C Morse, and G. M. Shearer. 1992. Role of T-cell derived cytokines in the down-regulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183-204.
360. Sieling, P. A., X.-H. Wang, M. K. Gately, J.-L. Oliveros, T. McHugh, P. F. Barnes, S. F. Wolt, L. Golkar M. Yamamura, Y. Yogi, K. Uyemura, T. H. Rea, and R. L. Modlin. 1994. IL-12 regulates T helper type 1 cytokine responses in human infectious diseases. J. Immunol. 153:3639-3647.
361. Simon, A. K., E. Seipelt, P. Wu, B. Wenzel, J. Braun, and J. Sieper. 1993. Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset. Clin. Exp. Immunol. 94:122-126.
362. Simon, H.-U., and K. Blaser. 1995. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol. Today 16:53-55.
363. Small, C. B., A. Kaufman, M. Armenaka, and D. L. Rosenstreich. 1993. Sinusitis and atopy in human immunodeficiency virus infection. J. Infect. Dis. 167:283-290.
364. Smith, C. A., H.-J. Gruss, T. Davis, et al. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349-1360.
365. Smith, K. J., H. G. Skelton, J. J. Drabick, W. F. McCarthy, R. Ledsky, and K. F. Wagner. 1994. Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease. Arch. Dermatol. 130:119-121.
366. Stanbope, P. E., A. Y. Liu W. Pavlat, P. M. Pitha, M. L. Clements, and R.F. Siliciano. 1993. An HTV-1 envelope protein vaccine elicits a functionally complex human CD4+ T-cell response that includes cytolytic T lymphocytes. J. Immunol. 150:4672-4686.
367. Steel, C., and T. B. Nutman. 1993. Regulation of IL-5 in onchocerciasis: a critical role for IL-2 J. Immunol. 150:5511-5518.
368. Stein, H., D. Y. Mason, J. Gerdes, N. O'Connor, J. Wainscoat, G. Pallesen, K. Gatter, B. Falini, G. Delsol, H. Lemke, R. Schwarting, and K. Lennert. 1985. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Stemberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 11:148-149.
369. Stern, M., L. Meagher, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads 10 phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:3543-3549.
370. Stevens, D.A. 1995. Coccidioides immitis, p. 2365-2375. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease, 4th ed. Churchill Livingstone, New York.
371. Snndar, S., F. Rosenkaimer, and H. W. Murray. 1994. Saccessful treatment of refractory visceral leishmaniasis in India using antimony plus interferongamma. J. Infect Dis. 170:659-662.
372. Surcel, H.-M., M. Troye-Blomberg, S. Paulie, G. Andersson, C. Moreno, G. Pasvol, and J, Ivanyi. 1994. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens, Immunology 81:171-176.
373. Tabata, H., O. Ishikawa, K. Ohnishi, and H. Ishikawa. 1992. Kimura's disease with marked proliferation of HLA-DR-CD4+ T-cells in the skin, lymph node and peripheral blood Dermatology 184:145-148.
374. Tamashiro, V.G, H. H. Perez, and D. E. Griffin. 1987. Prospective srudy of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr. Infect. Dis. J. 6:451-454.
375. Tang, Y.-W., and B. S. Graham. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxie T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin. Invest, 94:1953-1958.
376. Tang, Y.-W., and B. S. Graham. 1995. Interleukin 12 treatment during immunization elicits a Th1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:734-738.
377. Taylor-Robinson, A. W., R. S. Phillips, A. Severn, S. Moncada, and F. Y. Liew. 1993. The role of Th1 and Th2 cells in a rodent malaria infection. Science 260:1931-1934.
378. Ten, R. M., G. M. Kephart, M. Posada, I. Abaitua, I. Soledevilla, E. M. Kilbourne, S. L. Dunnette, and G. J. Gleich. 1990, Participation of eosinophils in the toxic oil syndrome, Clin. Exp. Immunol. 83:313-317.
379. Tendler, C. L., J. D. Barton, J. Jalfe, D. Danielpour, M. Charley, J. P. McCoy, M. R. Pittelkow, and T. A. Waldmann. 1994. Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res. 54: 4430-4435.
380. Tepper,R. L., R. L. Coftman, and P. Leder. 1992. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548-551.
381. Tepper, R. L, D. A. Levinson, B. L. Stronger, J. Campos-Torres, A. K. Abbas, and P. Leder. 1990. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62:457-467.
382. Teppler, H., G. Kaplan, K. Smith, P. Cameron, A. Montana, P. Meyn, and Z. Cohn. 1993. Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 167:291-298.
383. Tomioka, R., K. Mamagachi, and R. Ohno. 1992. Elevated interleukin 2 levels in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis. Ann. N. Y. Acad. Sci. 650:347-350.
384. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14:335-338.
385. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
386. Tsicopoulos,A., Q. Hamid, V. Varney, S. Ying R. Moqbel, S. R. Durham, and A. B. Kay. 1992. Preferential messenger RNA expression of Th1 type cells (IFN-gamma, IL-2) in classical delayed (tuberculin) hypersensitivity reactions in humans. J. Immunol 148:2058-2061.
387. Tsutsui, H., Y. Mizoguchi, and S. Morisawa. 1991. There is no correlation between function and lymphokine production of HBs-antigen-specific human CD4+-cloned T cells. Scand. J. Immunol. 32:433-444.
388. Turano, A., A. Balsari, E. Viani, S. Landolfo, L. Zanoni, F. Gargullo, and A. Caruso. 1992. Natural antibodies to gamma-interferon interfere with the immunomodulating activity of the lymphokine. Proc. Natl. Acad. Sci. USA 89:4447-4451.
389. Ulmer, J. B., J. J. Donnelly, and S. E. Parker. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
390. Van Voorhis, W. C., L. K. Barrett, D. M. Koelle, J. M. Nasio, F.A. Plummer, and S. A. Lakehart. 1996. Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J. Infect Dis. 173:491-495.
391. Vellupilla, P., and D. A. Harn. 1994. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4-F T-cell subsets. Proc. Natl. Acad. Sci. USA 91:18-22.
392. Via, C. S., G. C. Tsokos, B. Bermas, M. Clerici, and G. M. Shearer. 1993. T cell antigen-presenting cell interactions in human systemic lupus erythematosus: evidence for heterogenous expression of multiple defects. J. Immunol. 151:3914.
393. Vigano, A., N. Principi, L. Crupi, J. Onorato, Z. G. Viacenzo, and A. Salvaggio. 1995, Elevation of IgE in HIV-infected children and its correlation with the progression of the disease. J. Allergy Clin. Immunol. 95: 627-632.
394. Vigano, A., N. Principi, M. L. Villa, C. Riva, L. Crupi, D. Trabattoni, G. M. Shearer, and M. Clerici. 1995. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression. J. Pediatr. 126:368-374.
395. Vingerboets, J., G. Vanhams, L. Kestens, G. Penne, G. Leronx-Roels, and P. Gigase. 1994. Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production. Immunol. Lett. 39:163-168.
396. Vossen, A. C. T. M., and H. F. J. Savelkoul. 1994. Cytokines in clinical and experimental transplantation. Mediat. Inflamm 3:403-410.
397. Vowels, B. R., M. Cassin, E. C. Vonderbeid and A. H. Root. 1992. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion resembles murine Th2 cells. J. Invest. Dermatol. 99:90-94.
398. Vyakarnam, A. 1994. Mechanisms for an opposing role for Th1/2 cells in AIDS. Res. Immunol. 145:618-624.
399. Vyakarnam, A., and P. M. Matear. 1994. TH1/TH2 cells specific for HIV-1 gag-24. Evidence for opposing effects on HIV-infected cells, p. 169-191. In S. Romagnani, G. Del Prete, and A. K. Abbas (ed.), Cytokines: basic principles and practical applications. Ares-Serano Symposia Publications, Rome.
400. Wachter, H., D. Fuchs, and A. Hausen. 1992. Biological significance of cytokine-induced pteridine synthesis, p. 48-54, In H. Wachter, D, Fuchs, A. Hausen, G. Reibenegger, G. Weiss, E. R. Werner, and G. Werner-Elmeyer (ed.), Neopterin: biochemistry - methods - clinical application. Walter de Gruyter, Berlin.
401. Walker, C., W. Bauer, R. K. Braun, G. Menz, P. Braun, F. Schwarz, T. H. Hansel, and B. Villiger. 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir, Crit. Care Med. 150:1038-1048.
402. Wallis, R. S., and J. J. Ellner. 1994. Cytokines and tuberculosis. J. Leukocyte Biol. 55:676-681.
403. Wanidworanum, C., and W. Strober. 1993. Predominant role of tumor necrosis factor-alpha in human moneyte IL-10 synthesis. J. Immunol. 151:6853.
404. Ward, B. J., and D. E. Griffin. 1993. Changes in cytokioe production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin. Immunol. Immunopathol. 67:171-177.
405. Wegman, T. G., H. Lin, L. Guilbert, and T. R. Mosmaan. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today 14:353.
406. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, K. E. Baehus, A. F. Haney, and D. L. Granger. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184-1195.
407. Weiss, G., D. Fuchs, A. Hansen, G. Reibneggar, E. R. Werner, G. Werner-Felmayer, E. Semenitz, M. P. Dierich, and H. Wacheter. 1993. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett. 321:89-92.
408. Weissman, D., G. Poli, and A. S. Fanci. 1995. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocyte lineage. J. Acquired Immune Defic. Syndr. 9:442-449.
409. Weller, P. F. 1991. Tne immunobiology of eosinophils. N. Engl. J. Med. 324:1110-1118.
410. Weller, P. F., and G. Bubley. 1994. The hypereosinophilic syndrome. A review. Blood 83:2759-2779.
411. Weller, P. F., W. L. Marshall, D. R. Lucey, A. M. Dvorak, T. H. Rand, and R. W. Finberg. 1995. Infection, apoptosis and killing of mature human eosinophils by human immunodeficiency viras-1. Am. J. Respir. Mol. Rev. 13:610-620.
412. Weller, P. F., T. H. Rand, T. Barrett, A. Elovie, D. T. Wong, and R. W. Finberg. 1993. Accessory cell function of human eosinophils: HLA-DR dependent, MHC-restricted antigen-presentation and interteukin-1 alpha formation. J. Immunol. 150:2554-2562.
413. Wesseilngh, S. L., and D. E. Griffin. 1994. Local cytokine responses during acute and chronic viral infections of the central nervous system. Semin. Virol 5:457-463.
414. Weyand, C. M., K. C. Hicock, G. G. Hunder, and J. J. Gerozny. 1994. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann. Intern. Med. 121:484-491.
415. White, J. D., S. L. Zaknoen, C. Kasten-Sportès, L. E. Top, M. N. Ed, L. Navarro-Roman, D. L. Nelson, and T. A. Waldmann, 1995. Infectious complications and immunodeficiency in patients with HTLV-1 associated adult T-cell leukemia/lymphoma. Cancer 75:1598-1607.
416. Whiteside, T. L. 1994. Cytokine measurements and interpretations of cytokine assays in human disease. J. Clin. Immunol. 14:327-339.
417. Wierenga, E. A, M. Snoek, C. De Groot, I. Chretien, J. D. Bos, H. M. Jansen, and M. L. Kapsenberg. 1990. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J. Immunol. 144:4651-4656.
418. Wierenga, E. A., M. Snoek, H. M. Jansen, J. D. Bos, R. A. W. van Lier, and M. L. Kapsenberg. 1991. Human atopen-specific types 1 and 2 T helper cell dones. J. Immunol. 147:2942-2949.
419. Wilkinson, P. C., and F. Y. Liew. 1995. Chemoattraetion of human blood T lymphocytes by interleukin-15. J. Exp. Med. 181:1255-1259.
420. Wright, D. N., R. P. Nelson, and D. F. Ledford. 1990 Serum IgE and human immunodeficiency (HIV) infection. J. Allergy Clin. Immunol. 85:445-452.
421. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature (London) 376:594-596.
422. Yamamura, M., R. L. Modlin, J. D. Ohmen, and R. L. Moy. 1993. Local expression of antiinfiammatory cytokines in cancer. J. Clin. Invest, 91:1005-1010.
423. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-280.
424. Yamamura, M., X.-H. Wang, J. D. Obmen, K. Uyemura, T. H. Rea, B. R. Bloom, and R. L. Modin. 1992. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 149:1470-1475.
425. Yang, J., M. K. Hagan, and M. K. Offermnn. 1994. Induction of IL-6 gene expression in Kaposi's sarcoma. J. Immunol. 152:943.
426. Vokoyama, H., M, Takaeda, T. Wada, M. Ogi, N. Tomosugi, T. Takabatake, T. Abe, M. Yoshimura, H. Kida, and K.I. Kobayashi. 1992. Intraglomerular expression of MHC class II and Ki-67 antigens and serum gammainterferon levels in IgA nephropathy, Nephron 62:169-175.
427. Yoshizaki, K., T. Matsuda, N. Nishimoto, T. Kuritani, L. Tacho, K. Aozasa, T. Nakahata, H. Kawai, H. Tagoh, T. Komori, S. Kishimoto, T. Hirano, and T. Kishimoto. 1989. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74:1360-1367.
428. Yssel, H., S. Fasler, J. E. de Vries, and R. de Waal Malefyt. 1994. IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 clones. Int Immunol. 6:1091-1096.
429. Yssel, H., T. Nakamoto, P. Schneider, V. Freitas, C. Collins, D. Webb, N. Mensi, C. Soderberg, and G. Pelz. 1990. Analysis of T lymphocyte clones from the synovial fluid and blood of a patient with Lyme arthritis. Int. Immunol. 2:1081-1089.
430. Yssel, H., M.-C. Shanafelt, C. Soderberg, P. V. Schneider, J.Anzola, and G. Peltz. 1991. Borrelia burgdorferi activates a T helper type-1 T cell subset in Lyme arthritis. J. Exp. Med. 174:593-601.
431. Zhang, M., J. Gong, B. E. Jones, R. L. Modlin, and P. F. Barnes. 1994. T cell cytokine responses in persons with tuberculosis and human immunodeficiency infection. J. Clin. Invest. 94:2435-2442.
432. Zwingenberger, K., G. Harms, C Pedrosa, S. Omena, B. Sendkamp, and S. Neiger. 1990. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous IL-4 over IFN-gamma production. Clin. Immunol. Immunopathol. 57:242.
433. Zwingenberger, K., A. Hohmann, M. C. De Brito, and M. Ritter. 1991. Impaired balance of interleukin-4 and IFN-gamma production in infections with Schistosoma mansoni and intestinal nematodes. Scand. J. Immunol. 34:243-256.